Cellebrite DI Q4 2024 Adj. EPS $0.10, Inline, Sales $109.000M Beat $107.183M Estimate

Benzinga
02-13

Cellebrite DI (NASDAQ:CLBT) reported quarterly earnings of $0.10 per share which met the analyst consensus estimate. This is a 9.09 percent decrease over earnings of $0.11 per share from the same period last year. The company reported quarterly sales of $109.000 million which beat the analyst consensus estimate of $107.183 million by 1.70 percent. This is a 17.19 percent increase over sales of $93.013 million the same period last year.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10